Recruiting studies: Mitochondrial Encephalomyopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
Phase 2 · 1 location(s) · Kenneth Myers, MD · NCT04802707 KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Phase 3 · 10 location(s) · Khondrion BV · NCT06451757 The International Registry for Leigh Syndrome
Phase N/A · 1 location(s) · The University of Texas Health Science Center, Houston · NCT03137355 MNGIE Natural History Study
Phase N/A · 1 location(s) · University of Cambridge · NCT07627217 Global Registry and Natural History Study for Mitochondrial Disorders
Phase N/A · 33 location(s) · LMU Klinikum · NCT05554835 North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Phase N/A · 17 location(s) · Columbia University · NCT01694940 Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
Phase 1 · 1 location(s) · Michio Hirano, MD · NCT05241262 Patterns of Neurodevelopmental Disorders
Phase N/A · 1 location(s) · Richard Frye · NCT06213090 Natural History Study of Patients with HPDL Mutations
Phase N/A · 1 location(s) · University of California, San Diego · NCT05848271 Natural History Study - Mitochondrial Disease
Phase N/A · 1 location(s) · Columbia University · NCT01532791

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.